Kirkland & Ellis

Sarkis Jebejian

Deals
3
Latest
Jun 2026
Most deals in
Biotech

Firm

Deals by year
Sarkis Jebejian: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Sarkis Jebejian was named on, most recent first
Jun 2026 Cursor –SpaceXAcquisitionLegal adviser to Cursor (target)Announced60,000.0AI+1SpaceX acquisition of Cursor
May 2026 LimmaTech Biologics AG –Eli Lilly and CompanyAcquisitionLegal adviser to Eli Lilly and Company (acquirer)Pending780.0BiotechEli Lilly and Company acquisition of LimmaTech Biologics AG
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Eli Lilly and Company (acquirer)Announced7,000.0Biotech+2Eli Lilly and Company acquisition of Kelonia Therapeutics

Deals where Sarkis Jebejian is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.